
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.950 | 1.020 | 0.070 |
Shares | 99.060 | 99.060 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.690 | 19.611 |
Price to Book | 3.789 | 3.844 |
Price to Sales | 1.684 | 2.221 |
Price to Cash Flow | 13.063 | 14.840 |
Dividend Yield | 1.673 | 1.499 |
5 Years Earnings Growth | 7.687 | 10.202 |
Number of long holdings: 51
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 7.05 | 789.80 | +2.34% | |
AstraZeneca | GB0009895292 | 6.44 | 10,436.0 | -0.57% | |
Roche Holding Participation | CH0012032048 | 6.36 | 256.20 | +0.47% | |
Novo Nordisk B | DK0062498333 | 6.17 | 433.6 | +0.12% | |
J&J | US4781601046 | 6.02 | 164.77 | +6.19% | |
Lonza Group | CH0013841017 | 3.78 | 569.80 | +1.10% | |
UnitedHealth | US91324P1021 | 3.48 | 292.46 | +0.26% | |
Sanofi | FR0000120578 | 3.25 | 83.20 | +0.60% | |
DexCom | US2521311074 | 3.24 | 84.13 | -0.77% | |
Thermo Fisher Scientific | US8835561023 | 3.02 | 416.31 | -0.40% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
DNB Global indeks NOK | 120.24B | -5.77 | 16.33 | 12.79 | ||
DNB Teknologi NOK | 82.2B | 5.85 | 28.33 | 21.58 | ||
Pensjonsprofil 80 | 54.67B | 1.61 | 8.63 | 8.08 | ||
DNB Global IV | 44.41B | 0.49 | 18.99 | 13.64 | ||
Pensjonsprofil 50 | 29.23B | 2.07 | 6.89 | 6.18 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review